| Category: | Health, |
|---|---|
| Address: | 336 Hill Ave, Nashville, TN 37210, USA |
| Postal code: | 37210 |
| Phone: | (855) 642-8438 |
| Website: | http://diagnovus.com/ |
| Monday: | 8:00 AM – 5:00 PM |
|---|---|
| Tuesday: | 8:00 AM – 5:00 PM |
| Wednesday: | 8:00 AM – 5:00 PM |
| Thursday: | 8:00 AM – 5:00 PM |
| Friday: | 8:00 AM – 5:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Diagnovus, use the form below and your opinion, advice or comment will appear in this space.
James Stover, PhD, Diagnovus 855-642-8438, james.stover@diagnovus.com. Release Summary. Diagnovus, LLC, has entered into a license agreement with Cincinnati Children's Hospital Medical Center to commercialize the first genomic assay to help diagnose and treat eosinophilic esophagitis.
(855) 642-8438. Founded in 2011 and based in Nashville, TN, Diagnovus's mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects.
Diagnovus is a specialized molecular diagnostic company focused on delivering personalized information and services to physicians treating patients suffering from underserved, aggressive, and lesser-known diseases. The company's mission is to improve...Show all.
Diagnovus, a molecular diagnostics company focused on underserved, aggressive, and lesser-known diseases, announced the launch of the Engauge GI Barrett's Esophagus genomic assay to predict the risk of progression to high-grade dysplasia or esophageal Diagnovus, 855-642-8438.
www.diagnovus.com. Latest From Diagnovus LLC. Bookmark. Diagnovus LLC. Senior Management. James Stover, PhD, Pres. David Barkhurst, VP, Sales & Mktg. Contact Info.
Diagnovus announced the launch of Engauge-cancer-DLBCL, the first commercial gene expression assay to aid physicians in risk stratification and treatment of patients with diffuse large B-cell lymphoma (DLBCL). For more information call (855) 642-8438 or visit www.diagnovus.com.
Diagnovus is a Nashville-based company founded in 06/2011. See Diagnovus's revenue, employees, and funding info on Owler, the world's largest community-based business insights Diagnovus's Competitors, Revenue, Number of Employees, Funding and Acquisitions. 855-642-8438.
Diagnovus was acquired by Aegis Sciences on January 6, 2015. Healthcare Services Company. 336 Hill Avenue, Suite #302, Nashville, Tennessee 37210 United States, (855) 642-8438 www.diagnovus.com.
Diagnovus. This is a profile preview from the PitchBook Platform. Diagnovus General Information. Description. Provider of molecular diagnostics targeting rare forms of cancer, including pediatric cancers.
Clinical Impact of a Genetic Test in the Treatment and Surveillance of Barrett's Esophagus: A National Community-based Study of Gastroenterologists James Stover, PhD, Vivek Yellore, PhD, Stephen Meltzer, MD, Yulan Cheng, PhD, Diagnovus, Nashville, TN, Johns Hopkins University, Baltimore...